Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-060962 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,500
Total Value
$43,666.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | Sep 8, 2026 | Exercise/Conversion | 2,500 | $1.01 | $2,525.00 | 19,717 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Sep 8, 2026 | Sale | 2,500 | $16.46 | $41,141.50 | 17,217 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Sep 8, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 274,430 | Direct | โ | View Details |